Clinical Trial Update: Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing reversal of neuromuscular blockade with sugammadex versus neostigmine plus glycopyrolate in burn surgery patients has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• Glycopyrrolate (glycopyrrolate)
• Neostigmine (neostigmine)
• Sugammadex (sugammadex)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Burns | Phase 3 | Status: COMPLETED